Citations

Mayo Clinic

Clear

166 citation(s) found for "Baddour, L M".

P-808. Enterococcal Bloodstream Infection and Infective Endocarditis in a Population-Based Cohort: An Expanded Rochester Epidemiology Project Investigation
Bayless, David S. , Lahr, Brian D. , Hagan, Grace , Bayless, David, Baddour, Larry M. , Cao, Jenny , DeSimone, Daniel C.

Open Forum Infectious Diseases | January 29, 2025 | Volume: 12 | Issue: Supplement_1 | Pages: No page available

10.1093/ofid/ofae631.1000 Get It

Abstract Background The Rochester Epidemiology Project (REP) has been used to examine numerous infectious and non-infectious entities in a population-based approach in Olmsted County, Minnesota. To further investigate patterns of enterococcal bloodstream infection (BSI), we used the Expanded Rochester Epidemiology Project (E-REP) to include additional surrounding counties to conduct a retrospective population-based study of adult patients who developed enterococcal BSI, with or without infective endocarditis (IE). Methods The E-REP population under study included eight counties in southeastern Minnesota (including Olmsted County), representing a total population of over 250,000 individuals. Adults (age ≥ 18 years) diagnosed with an initial episode of enterococcal BSI with or without enterococcal IE between January 1, 2018 and December 31, 2022 were included; patients with either polymicrobial BSI with enterococci or a previous bout of enterococcal BSI before the study period were excluded. Cases of enterococcal BSI and IE were identified using ICD-10 codes and underwent complete medical record review. Patient characteristics, microbiology, antibiotic regimens, infectious complications, and outcomes were collected. Results A total of 113 cases of enterococcal BSI were identified over the five-year study period. The age- and sex-adjusted incidence rate of enterococcal BSI was 6.9 per 100,000 person-years, with a significantly higher rate among males than females (Figure 1). BSI incidence rate varied by age, with patients 80 years or older having the highest incidence rate (Figures 1 and 2). Twenty-two cases of enterococcal IE were identified, yielding an overall IE prevalence of 20.8% (Figure 3). The cumulative mortality rate at 12 months was high at 41.7% (Figure 3). Five patients (4.4%) had a relapse of enterococcal BSI, defined as recurrence of BSI after negative follow-up blood cultures and within 12 weeks of the initial BSI. Conclusion This is the first population-based investigation that has focused on the epidemiology and clinical profile of patients with enterococcal BSI and complicating IE in a US population. This included an IE prevalence of 20.8%, which should be considered when evaluating and managing patients with enterococcal BSI. Disclosures Larry M. Baddour, MD, UpToDate, Inc.: Royalty payments (authorship duties).
P-940. Diagnostic Workup of Bacteremia Post TAVR, a Single Center Experience Over a Decade
Villareal, Kenneth , Zorn, George L., Almoghrabi, Omar, Tadros, Peter, Marikanti, Goutham, Li, Yanming , Atrouni, Wissam El , Almoghrabi, Omar , Baddour, Larry M.

Open Forum Infectious Diseases | January 29, 2025 | Volume: 12 | Issue: Supplement_1 | Pages: No page available

10.1093/ofid/ofae631.1131 Get It

Abstract Background Prosthetic valves are considered a risk factor for endocarditis however diagnosing prosthetic valve endocarditis (PVE) is complicated by acoustic shadowing on echocardiography. In 2023, the ISCVID published an update to the Duke Criteria (Duke 2023) which intended to increase the sensitivity in diagnosing PVE. The purpose of this study was to examine how TAVR infective endocarditis (TAVR-IE) was diagnosed at our institution 90 Day Mortality Kaplan Meier Curve Methods HERON was utilized to match cases between ACC/STS databases and the EMR at The University of Kansas Health System (TUKHS). Patients with bacteremia occurring after a TAVR were reviewed. Each case was evaluated if they met rejected/possible/definitive endocarditis criteria in the Modified Duke Criteria (Duke 2005) and the Duke 2023 Criteria. To adjudicate the diagnosis, an expert panel reviewed all cases that met definitive endocarditis criteria in any edition of the Duke Criteria. Results A total of 2371 TAVRs were conducted at TUKHS from 2012 to 2023. We identified 146 cases of post procedure bacteremia. We excluded 53 cases leaving 93 in the cohort. Transeophageal echocardiography was utilized in about half of the cases (TTE 73, TEE 45). F-FDG positron emission tomography/CT was done in six patients and Cardiac CT in one patient. Cultures returning with Enterococcus spp (16). viridans group streptococci (15), and Staphylococcus spp. (15) had similar incidence. About half had either atypical organisms (40) on 2005 Duke criteria or polymicrobial growth (7). Definitive criteria were met in 18 and 21 patients for the Duke 2005 and Duke 2023 Criteria respectively. Two cases had minor microbiological criteria upgraded to major in Duke 2023. One case was promoted to definitive endocarditis based on Cardiac CT. Upon adjudication the panel agreed with Duke 2023 Criteria classification. Sensitivity was calculated 85%/100% for Duke 2005 and Duke 2023 Criteria respectively. Kaplan Meier curves calculated no significant difference of 3 month mortality between TAVR patients who had met definitive criteria and those who did not. (Figure #1) Conclusion The 2023 ISCVID Duke Criteria in this study appeared to have superior sensitivity for TAVR-IE when compared to the older Modified Duke Criteria published in 2005. Disclosures Larry M. Baddour, MD, UpToDate, Inc.: Royalty payments (authorship duties). Wissam El Atrouni, MD, ViiV Healthcare: Advisor/Consultant
P-832. The Skip Phenomenon in Patients with Staphylococcus lugdunensis Bloodstream Infection
Gasca, Luis Gerardo Domínguez , Streck, Nicholas , Gasca, Luis R, Crowley, Patrick, Baddour, Larry M. , DeSimone, Daniel C.

Open Forum Infectious Diseases | January 29, 2025 | Volume: 12 | Issue: Supplement_1 | Pages: No page available

10.1093/ofid/ofae631.1024 Get It

Abstract Background Staphylococcus lugdunensis (SL) is a coagulase-negative staphylococcus with virulence comparable to that of Staphylococcus aureus. The “skip phenomenon” (SP) is a pattern where blood cultures are intermittently negative before final clearance of bloodstream infection (BSI). SP is well-documented in S. aureus bacteremia but has not been described previously in SL. In this report, we present a cohort with SL BSI and describe its prevalence and their clinical features and outcomes. Methods We conducted a retrospective review of patients with blood cultures positive for SL in samples referred to the Mayo Clinic reference lab between June 2012 and June 2022. We assessed clinical characteristics, including time to positivity, prevalence of the skip phenomenon (defined by a positive culture after 24 hours of negative cultures), patient demographics including Charlson Comorbidity Index, mortality and length of hospital stay. Results We identified 55 patients with SL BSI and 33 of them had enough laboratory data to determine the prevalence of the skip phenomenon. SP was present in 5 of 33 (15.2%) patients. For all patients with SL BSI, the median age was 67 years (interquartile range [IQR] 61-79); mean CCI in the group with SP was 5.6 (standard deviation 2) and those without SP was 5.9 (standard deviation 2.7); median duration of bacteremia was 3 days (IQR 1-4); median hospital length of stay was 14 days (IQR 8-20); and 1-year mortality was 45%. Oxacillin susceptibility was present in 33 of 34 cases. Conclusion A total of 15% of patient cases with SL BSI demonstrated the SP. Recognition of the SP in patients with SL BSI is important as this may impact duration of antibiotic therapy and timing of long-term cardiovascular device placement. Disclosures Larry M. Baddour, MD, UpToDate, Inc.: Royalty payments (authorship duties).
Comprehensive Assessment of the Risk of Symptomatic Embolism in Patients With Infective Endocarditis
Santos-Patarroyo, Sebastián , Quintero-Martinez, Juan Andres , Lahr, Brian D. , Chesdachai, Supavit , Villarraga, Hector R. , Michelena, Héctor I. , Baddour, Larry M. , Patarroyo, Sebastian Santos , Quintero-Martinez, Juan A , Villarraga, Hector R , Michelena, Hector I , Baddour, Larry , Chesdachai, Supavit , DeSimone, Daniel C.

Journal of the American Heart Association | January 23, 2025 | Volume: 14 | Issue: 3 | Pages: No page available

10.1161/jaha.124.036648 | PMID 39846279 Get It

Background Echocardiographic evaluation of vegetations is crucial in infective endocarditis ( IE ). Although several studies have noted a link between larger vegetations and an increased risk of embolization, a more comprehensive evaluation of vegetation characteristics in a contemporary cohort has not been conducted. Our study aimed to define the short‐term risk of symptomatic embolization in patients with IE . Methods and Results The Mayo Clinic IE registry was screened to identify patients from 2015 to 2021 who had undergone transesophageal echocardiography. Multivariable subdistribution hazards regression analysis was used to identify factors associated with the cumulative incidence of symptomatic embolism over 30 days accounting for the competing risk of death. Overall, 779 patients with IE were included, of whom 517 (66.4%) were men, median age was 65.0 ( interquartile range, 52.9–74.8) years, and 89.3% were White. In total, 234 patients had a symptomatic embolic event, a 30‐day cumulative incidence of 30.2%. In multivariable analysis, a highly mobile vegetation was the strongest predictor of embolism ( P <0.001). Vegetation length with interaction of IE type was also associated with embolic risk ( P <0.001), with a stronger effect in native valve IE ( P interaction=0.001). Other associated factors included multiple vegetations, younger age, and Staphylococcus aureus . A nomogram that incorporated these factors was constructed to facilitate the prediction of embolic risk. Conclusions Highly mobile, larger vegetations are associated with embolic events. Embolic risk could be assessed by evaluating length as a continuous variable, alongside other echocardiographic findings, using a newly developed scoring tool; external validation is warranted.
Identification of the Skip Phenomenon Among Patients With Staphylococcus lugdunensis Infective Endocarditis: A Retrospective Review
Crowley, Patrick , Gasca, Luis Gerardo Domínguez , Katragadda, Silpita , Quintero-Martinez, Juan Andres , Baddour, Larry M. , DeSimone, Daniel C. , Crowley, Patrick D , Gasca, Luis R , Quintero-Martinez, Juan A , Baddour, Larry , DeSimone, Daniel C

Open Forum Infectious Diseases | January 13, 2025 | Volume: 12 | Issue: 1 | Pages: No page available

10.1093/ofid/ofaf015 | PMID 39845017 Get It

Abstract The skip phenomenon (SP) is a pattern where blood cultures are intermittently positive before final clearance. We report that one-third of patients with Staphylococcus lugdunensis infective endocarditis experienced the SP. Patients with the SP experienced both a longer duration of bacteremia and hospital stay, with a higher 1-year mortality rate.
Left Ventricular Assist Device Versus Cardiac Implantable Electronic Device Infections: Distinct Entities, Distinct Suppression Strategies
Chesdachai, Supavit , Chesdachai, Supavit , Baddour, Larry M. , DeSimone, Daniel C.

Clinical Infectious Diseases | December 24, 2024 | Volume: 80 | Issue: 3 | Pages: 497-500

10.1093/cid/ciae647 | PMID 39718372 Get It

Abstract A distinction between infections of left ventricular assist devices and cardiac implantable electronic devices is warranted as they differ markedly in incidence, microbiologic profiles, clinical presentations, and extraction feasibility. These differences necessitate tailored suppressive antibiotic therapy (SAT) strategies. This commentary highlights the need for device-specific SAT approaches.
Echocardiographic findings and subsequent risk of native valve endocarditis
Quintero-Martinez, Juan Andres , Villarraga, Hector R. , Lahr, Brian D. , Thornhill, Martin H. , Anavekar, Nandan S., Thornhill, M H , Quintero-Martinez, Juan A , Hindy, Joya-Rita , Dayer, Mark , O’Horo, John C. , Michelena, Héctor I. , Sendi, Parham , DeSimone, Daniel C. , Baddour, Larry M.

Exploration of Cardiology | September 25, 2024 | Volume: 2 | Issue: 5 | Pages: 204-216

10.37349/ec.2024.00034 Get It

Aim: The association of echocardiographic findings and subsequent risk of left-sided native valve endocarditis (LS-NVE) is undefined. The aim of this study was to determine if transthoracic echocardiography (TTE) measurements are associated with the subsequent development of LS-NVE in patients without cardiac predisposing conditions. Methods: Institutional databases were evaluated for adults diagnosed with LS-NVE from 2008 to 2020. Patients with prosthetic valves, cardiovascular implantable electronic devices, intracardiac devices, injection drug use, and predisposing cardiac conditions were excluded. Only patients who had a TTE performed 6 months to 3 years before the development of LS-NVE were included as cases. Controls were patients within the same Mayo location with a TTE report and were matched in a 1:3 ratio according to age, gender, Charlson comorbidity index, and echocardiography date. Results: There were 148 cases and 431 matched controls. As compared to controls, infective endocarditis (IE) cases had a higher prevalence of diabetes mellitus (46.6% vs. 30.4%) and chronic kidney disease (46.6% vs. 28.1%) (P < 0.001). Left ventricular outflow tract velocity (P = 0.017), left ventricular ejection fraction (P = 0.018), and E:e’ ratio (P = 0.050) were associated with LS-NVE. Conclusions: Echocardiographic measurements were associated with subsequent LS-NVE development in this pilot study. A larger cohort of LS-NVE patients, however, is needed to validate these findings.
Outcome of Corynebacterial Bloodstream Infection in Patients With Cardiac Implantable Electronic Devices: A Brief Report and Systematic Review
Chesdachai, Supavit , Baddour, Larry M. , Sohail, M. Rizwan , Palraj, Bharath Raj, Madhavan, Malini , Tabaja, Hussam , McGinnis, Michele , Fida, Madiha , Palraj, Raj , McGinnis, Michele T, Challener, Douglas , Baddour, Larry , Sohail, M Rizwan , Palraj, Raj , Fida, Madiha , Chesdachai, Supavit , McGinnis, Michele T , Tabaja, Hussam , Challener, Douglas W. , DeSimone, Daniel C.

Open Forum Infectious Diseases | July 27, 2024 | Volume: 11 | Issue: 8 | Pages: No page available

10.1093/ofid/ofae441 | PMID 39161858 Get It

Abstract Cardiac implantable electronic device infection in the context of corynebacterial bloodstream infection (BSI) remains poorly understood. From 2012 to 2023 at Mayo Clinic, 4 of 12 patients with corynebacterial BSI had cardiac implantable electronic device infection: 1 patient was diagnosed during a relapsing BSI episode. Undefined source, persistent BSI, and the presence of a prosthetic cardiac valve were common characteristics.
Evaluating the Approach for Gram-Negative Bacteremia and Fungemia in Cardiovascular Implantable Electronic Device Infections From a Recent Infectious Diseases Society of America Guideline on Advanced Nuclear Imaging in Cardiovascular Infections
Chesdachai, Supavit , Chesdachai, Supavit , Baddour, Larry M. , DeSimone, Daniel C.

Clinical Infectious Diseases | June 12, 2024 | Volume: 80 | Issue: 3 | Pages: 694-695

10.1093/cid/ciae318 | PMID 38864584 Get It

Fostering Collaborative Teamwork—A Comprehensive Approach to Vascular Graft Infection Following Arterial Reconstructive Surgery
Tabaja, Hussam , Chesdachai, Supavit , Shah, Aditya , Wilson, Walter R., Baddour, Larry M. , Shah, Aditya S , Erben, Young M, Baddour, Larry , Chesdachai, Supavit , Tabaja, Hussam , Stevens, Ryan W. , DeMartino, Randall R. , Erben, Young , DeSimone, Daniel C.

Clinical Infectious Diseases | April 24, 2024 | Volume: 78 | Issue: 6 | Pages: e69-e80

10.1093/cid/ciae150 | PMID 38656065 Get It

Abstract Vascular graft infection (VGI) is one of the most serious complications following arterial reconstructive surgery. VGI has received increasing attention over the past decade, but many questions remain regarding its diagnosis and management. In this review, we describe our approach to VGI through multidisciplinary collaboration and discuss decision making for challenging presentations. This review will concentrate on VGI that impacts both aneurysms and pseudoaneurysms excluding the ascending thoracic aorta.